Flu-X
Commercial- Indications
- Flu, Cold
Company intelligence / Profile preview
Canagen Pharmaceuticals is a Canadian-based manufacturer of generic pharmaceuticals, APIs, and OTC products with global operations. The company has developed six novel drug candidates in cardiovascular, oncology, and Alzheimer’s areas—three of which have US patents—and a patented tuberculosis drug already approved in Ukraine and Bulgaria. The TB drug is undergoing clinical trials for multidrug-resistant forms. The company maintains collaborations with academic institutions in Canada, Germany, Bulgaria, and China[7][9].
3 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Canagen Pharmaceuticals Inc..